IL274162A - תרכובות סלנוגאלאקטוזיד לטיפול בהפרעות עמידות לאינסולין מערכתיות ושימוש בהן - Google Patents
תרכובות סלנוגאלאקטוזיד לטיפול בהפרעות עמידות לאינסולין מערכתיות ושימוש בהןInfo
- Publication number
- IL274162A IL274162A IL274162A IL27416220A IL274162A IL 274162 A IL274162 A IL 274162A IL 274162 A IL274162 A IL 274162A IL 27416220 A IL27416220 A IL 27416220A IL 274162 A IL274162 A IL 274162A
- Authority
- IL
- Israel
- Prior art keywords
- selenogalactoside
- compounds
- treatment
- insulin resistance
- systemic insulin
- Prior art date
Links
- 206010022489 Insulin Resistance Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000009885 systemic effect Effects 0.000 title 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/08—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762579343P | 2017-10-31 | 2017-10-31 | |
| PCT/US2018/032321 WO2019089080A1 (en) | 2017-10-31 | 2018-05-11 | Selenogalactoside compounds for the treatment of systemic insulin resistance disorders and the use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL274162A true IL274162A (he) | 2020-06-30 |
Family
ID=66332241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL274162A IL274162A (he) | 2017-10-31 | 2020-04-23 | תרכובות סלנוגאלאקטוזיד לטיפול בהפרעות עמידות לאינסולין מערכתיות ושימוש בהן |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3707149A1 (he) |
| JP (1) | JP2021501180A (he) |
| KR (1) | KR20200081443A (he) |
| CN (1) | CN111527097A (he) |
| AU (1) | AU2018361991A1 (he) |
| CA (1) | CA3080128A1 (he) |
| IL (1) | IL274162A (he) |
| WO (1) | WO2019089080A1 (he) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3475706B1 (en) * | 2016-06-27 | 2021-08-11 | Juno Therapeutics, Inc. | Mhc-e restricted epitopes, binding molecules and related methods and uses |
| EP3658172A4 (en) | 2017-07-25 | 2021-05-05 | TrueBinding, Inc. | TREATING CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND HIS LIGAND |
| CN113711036B (zh) | 2019-01-30 | 2025-03-18 | 真和制药有限公司 | 抗gal3抗体及其用途 |
| ES2974680T3 (es) | 2019-08-09 | 2024-07-01 | Idorsia Pharmaceuticals Ltd | Derivados de (2-acetamidil)tio-beta-D-galactopiranósidos |
| US12404295B2 (en) | 2019-08-09 | 2025-09-02 | Idorsia Pharmaceuticals Ltd | (Hetero)aryl-methyl-thio-beta-D-galactopyranoside derivatives |
| UA128909C2 (uk) | 2019-08-15 | 2024-11-20 | Ідорсія Фармасьютікалз Лтд | 2-гідроксициклоалкан-1-карбамоїльні похідні |
| PH12022550436A1 (en) * | 2019-08-29 | 2022-12-19 | Idorsia Pharmaceuticals Ltd | Alpha-d-galactopyranoside derivatives |
| JP7835441B2 (ja) * | 2019-12-06 | 2026-03-25 | トゥルーバインディング，インコーポレイテッド | Ｇａｌ３とインスリン受容体又はインテグリンとの相互作用を妨害する抗体及びそれらの使用方法 |
| CN116157151A (zh) | 2020-05-26 | 2023-05-23 | 真和制药有限公司 | 通过阻断半乳凝素-3治疗炎性疾病的方法 |
| AU2021356076A1 (en) | 2020-10-06 | 2023-06-08 | Idorsia Pharmaceuticals Ltd | Spiro derivatives of alpha-d-galactopyranosides |
| IL302421A (he) | 2020-11-02 | 2023-06-01 | Idorsia Pharmaceuticals Ltd | תולדות 2-הידרוקסיציקלואלקאן-1-קרבאמויל מעכבות גלקטין-3 |
| CN112190590A (zh) * | 2020-11-06 | 2021-01-08 | 牡丹江医学院 | 一种治疗动脉粥样硬化的硒核苷及其药物组合物 |
| JP7844491B2 (ja) | 2021-02-09 | 2026-04-13 | イドルシア・ファーマシューティカルズ・リミテッド | ヒドロキシヘテロシクロアルカン－カルバモイル誘導体 |
| EP4301748B1 (en) | 2021-03-03 | 2025-05-07 | Idorsia Pharmaceuticals Ltd | Triazolyl-methyl substituted alpha-d-galactopyranoside derivatives |
| JP1763359S (he) | 2023-09-08 | 2024-02-13 | ||
| WO2025084276A1 (ja) * | 2023-10-16 | 2025-04-24 | Ｃｙｎ－Ｋバイオ株式会社 | 肥満の処置 |
| JP1779661S (he) | 2024-05-09 | 2024-09-11 | ||
| JP1779660S (he) | 2024-05-09 | 2024-09-11 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3250581B1 (en) * | 2015-01-30 | 2021-01-20 | Galecto Biotech AB | Alpha-d-galactoside inhibitors of galectins |
| CN105318222B (zh) * | 2015-11-13 | 2018-07-27 | 南通亚泰蜡业工艺品有限公司 | 喷泉电子蜡烛 |
| JP7086008B2 (ja) * | 2016-03-04 | 2022-06-17 | ガレクティン・サイエンシーズ・リミテッド・ライアビリティ・カンパニー | ガレクチンに関連する疾患を予防および処置するためのセレノガラクトシド化合物およびその使用 |
-
2018
- 2018-05-11 JP JP2020524157A patent/JP2021501180A/ja active Pending
- 2018-05-11 AU AU2018361991A patent/AU2018361991A1/en not_active Abandoned
- 2018-05-11 CA CA3080128A patent/CA3080128A1/en active Pending
- 2018-05-11 KR KR1020207015450A patent/KR20200081443A/ko not_active Withdrawn
- 2018-05-11 WO PCT/US2018/032321 patent/WO2019089080A1/en not_active Ceased
- 2018-05-11 CN CN201880083771.8A patent/CN111527097A/zh active Pending
- 2018-05-11 EP EP18874558.2A patent/EP3707149A1/en not_active Withdrawn
-
2020
- 2020-04-23 IL IL274162A patent/IL274162A/he unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3707149A1 (en) | 2020-09-16 |
| CA3080128A1 (en) | 2019-05-09 |
| WO2019089080A9 (en) | 2020-07-23 |
| WO2019089080A1 (en) | 2019-05-09 |
| KR20200081443A (ko) | 2020-07-07 |
| CN111527097A (zh) | 2020-08-11 |
| JP2021501180A (ja) | 2021-01-14 |
| AU2018361991A1 (en) | 2020-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289650A (he) | אזולופירימידין לטיפול בהפרעות הקשורות לסרטן | |
| IL259751B (he) | תרכובות פוליציקליות והשימוש בהן בטיפול של הפרעות אימוניות | |
| IL290754A (he) | שימוש בפרידופידין לטיפול בחרדה ודיכאון | |
| ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
| IL290150A (he) | תרכובות ושיטות לטיפול בכאב כרוני | |
| PT3227237T (pt) | Dispositivo e a sua utilização no tratamento de fluidos por uv | |
| IL257173A (he) | תולדות אינסולין חדשות ושימושים רפואיים בהן | |
| IL272097A (he) | תרכובות למניעה וטיפול בהפרעות רפואיות ושימושים בהן | |
| GB201715194D0 (en) | Compounds and their therapeutic use | |
| IL281585B (he) | תרכובות סלנוגלקטוסיד למניעה ולטיפול במחלות הקשורות עם גלקטין ושימוש בהן | |
| GB201612165D0 (en) | Combinations for the treatment of type 2 diabetes | |
| GB201617064D0 (en) | Compounds and their therapeutic use | |
| GB201813312D0 (en) | Compounds and their therapeutic use | |
| IL275349A (he) | שימוש של hM4Di בטיפול בהפרעות פרכוס | |
| SI3452465T1 (sl) | Substituirani derivati 2,4-diamino-kinolina za uporabo v zdravljenju proliferativnih bolezni | |
| IL249485B (he) | תולדות של o–אלקיל–בנזילאידנגוואנידין ושימוש טיפולי לטיפול בהפרעות הקשורות בהצטברות של חלבונים שאינם מקופלים נכון | |
| IL274838A (he) | שימוש ב mir101 או mir128 בטיפול בהפרעות התקף | |
| IL273863B1 (he) | התקן לטיפול בטחורים | |
| IL271878A (he) | שימוש ב wx-uk1 ומטרים תרופה שלו, wx-671, לטיפול במצבים רפואיים שאינם סרטניים | |
| GB201915641D0 (en) | Glucose-responsive insulin analogs and methods of use thereof | |
| PL3148990T3 (pl) | Związki tiazolidynonu i ich zastosowanie w leczeniu zaburzeń psychiatrycznych neurologicznych i stanów zapalnych, w szczególności stanów zapalnych układu nerwowego | |
| GB201819430D0 (en) | Therapeutic compounds, nanoparticles and uses thereof | |
| PT3148990T (pt) | Compostos de tiazolidinona e seu uso no tratamento de condições psiquiátricas ou distúrbios neurológicos e inflamação, particularmente neuroinflamação | |
| HK40009960A (en) | Use of pridopidine for the treatment of anxiety and depression | |
| PL3370727T3 (pl) | Nieulegające biokonwersji c3-podstawione pochodne pregnenolonu do zastosowania w leczeniu zaburzeń związanych z nadużywaniem substancji |